Matches in SemOpenAlex for { <https://semopenalex.org/work/W3165752295> ?p ?o ?g. }
- W3165752295 abstract "Abstract Background We systematically assessed benefits and harms of the use of ivermectin (IVM) in COVID-19 patients. Methods Published and preprint randomized controlled trials (RCTs) assessing IVM effects on COVID-19 adult patients were searched until March 15, 2021 in five engines. Primary outcomes were all-cause mortality, length of stay (LOS), and adverse events (AE). Secondary outcomes included viral clearance and severe AEs. We evaluated risk of bias (RoB) using the Cochrane RoB 2·0 tool. Inverse variance random effect meta-analyses were performed with quality of evidence (QoE) evaluated using GRADE methodology. Subgroup analyses by severity of disease and RoB, and sensitivity analyses by time of follow-up were conducted. Results Ten RCTs (n=1173) were included. Controls were standard of care [SOC] in five RCTs and placebo in five RCTs. RCTs sample size ranged from 24 to 398 patients, mean age from 26 to 56 years-old, and severity of COVID-19 disease was mild in 8 RCTs, moderate in one RCT, and mild and moderate in one RCT. IVM did not reduce all-cause mortality vs. controls (RR 0.37, 95%CI 0.12 to 1.13, very low QoE). IVM did not reduce LOS vs. controls (MD 0.72 days, 95%CI -0.86 to 2.29, very low QoE). AEs, severe AE and viral clearance were similar between IVM and controls (low QoE for these three outcomes). Subgroups by severity of COVID-19 or RoB were mostly consistent with main analyses; all-cause mortality in three RCTs at high RoB was reduced with IVM. Sensitivity analyses excluding RCTs with follow up <21 days showed no difference in all-cause mortality. Conclusions In comparison to SOC or placebo, IVM did not reduce all-cause mortality, length of stay or viral clearance in RCTs in COVID-19 patients with mostly mild disease. IVM did not have effect on AEs or SAEs. IVM is not a viable option to treat COVID-19 patients." @default.
- W3165752295 created "2021-06-07" @default.
- W3165752295 creator A5035518209 @default.
- W3165752295 creator A5048292607 @default.
- W3165752295 creator A5068186079 @default.
- W3165752295 creator A5079281660 @default.
- W3165752295 creator A5081264787 @default.
- W3165752295 creator A5091347730 @default.
- W3165752295 date "2021-05-25" @default.
- W3165752295 modified "2023-10-18" @default.
- W3165752295 title "Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials" @default.
- W3165752295 cites W2067722551 @default.
- W3165752295 cites W2100224535 @default.
- W3165752295 cites W2135400982 @default.
- W3165752295 cites W2170952317 @default.
- W3165752295 cites W2970684805 @default.
- W3165752295 cites W3014962324 @default.
- W3165752295 cites W3016395404 @default.
- W3165752295 cites W3025457446 @default.
- W3165752295 cites W3034858522 @default.
- W3165752295 cites W3039963790 @default.
- W3165752295 cites W3045791157 @default.
- W3165752295 cites W3046396978 @default.
- W3165752295 cites W3046805425 @default.
- W3165752295 cites W3092176787 @default.
- W3165752295 cites W3099851774 @default.
- W3165752295 cites W3105654944 @default.
- W3165752295 cites W3105781131 @default.
- W3165752295 cites W3107056972 @default.
- W3165752295 cites W3110533808 @default.
- W3165752295 cites W3111068209 @default.
- W3165752295 cites W3120909857 @default.
- W3165752295 cites W3123539721 @default.
- W3165752295 cites W3126179459 @default.
- W3165752295 cites W3129282528 @default.
- W3165752295 cites W3135420706 @default.
- W3165752295 cites W3138655710 @default.
- W3165752295 cites W3143524848 @default.
- W3165752295 cites W3148825389 @default.
- W3165752295 cites W3150247726 @default.
- W3165752295 cites W3155833994 @default.
- W3165752295 cites W4206662199 @default.
- W3165752295 cites W4238803207 @default.
- W3165752295 cites W4242487040 @default.
- W3165752295 cites W4294215472 @default.
- W3165752295 doi "https://doi.org/10.1101/2021.05.21.21257595" @default.
- W3165752295 hasPublicationYear "2021" @default.
- W3165752295 type Work @default.
- W3165752295 sameAs 3165752295 @default.
- W3165752295 citedByCount "13" @default.
- W3165752295 countsByYear W31657522952021 @default.
- W3165752295 countsByYear W31657522952022 @default.
- W3165752295 crossrefType "posted-content" @default.
- W3165752295 hasAuthorship W3165752295A5035518209 @default.
- W3165752295 hasAuthorship W3165752295A5048292607 @default.
- W3165752295 hasAuthorship W3165752295A5068186079 @default.
- W3165752295 hasAuthorship W3165752295A5079281660 @default.
- W3165752295 hasAuthorship W3165752295A5081264787 @default.
- W3165752295 hasAuthorship W3165752295A5091347730 @default.
- W3165752295 hasBestOaLocation W31657522951 @default.
- W3165752295 hasConcept C105795698 @default.
- W3165752295 hasConcept C126322002 @default.
- W3165752295 hasConcept C129848803 @default.
- W3165752295 hasConcept C142724271 @default.
- W3165752295 hasConcept C168563851 @default.
- W3165752295 hasConcept C187960798 @default.
- W3165752295 hasConcept C197934379 @default.
- W3165752295 hasConcept C204787440 @default.
- W3165752295 hasConcept C27081682 @default.
- W3165752295 hasConcept C2776478404 @default.
- W3165752295 hasConcept C2779134260 @default.
- W3165752295 hasConcept C2780439572 @default.
- W3165752295 hasConcept C3008058167 @default.
- W3165752295 hasConcept C33923547 @default.
- W3165752295 hasConcept C44249647 @default.
- W3165752295 hasConcept C524204448 @default.
- W3165752295 hasConcept C71924100 @default.
- W3165752295 hasConcept C82789193 @default.
- W3165752295 hasConcept C95190672 @default.
- W3165752295 hasConceptScore W3165752295C105795698 @default.
- W3165752295 hasConceptScore W3165752295C126322002 @default.
- W3165752295 hasConceptScore W3165752295C129848803 @default.
- W3165752295 hasConceptScore W3165752295C142724271 @default.
- W3165752295 hasConceptScore W3165752295C168563851 @default.
- W3165752295 hasConceptScore W3165752295C187960798 @default.
- W3165752295 hasConceptScore W3165752295C197934379 @default.
- W3165752295 hasConceptScore W3165752295C204787440 @default.
- W3165752295 hasConceptScore W3165752295C27081682 @default.
- W3165752295 hasConceptScore W3165752295C2776478404 @default.
- W3165752295 hasConceptScore W3165752295C2779134260 @default.
- W3165752295 hasConceptScore W3165752295C2780439572 @default.
- W3165752295 hasConceptScore W3165752295C3008058167 @default.
- W3165752295 hasConceptScore W3165752295C33923547 @default.
- W3165752295 hasConceptScore W3165752295C44249647 @default.
- W3165752295 hasConceptScore W3165752295C524204448 @default.
- W3165752295 hasConceptScore W3165752295C71924100 @default.
- W3165752295 hasConceptScore W3165752295C82789193 @default.
- W3165752295 hasConceptScore W3165752295C95190672 @default.
- W3165752295 hasLocation W31657522951 @default.
- W3165752295 hasLocation W31657522952 @default.